- conflicts or gaps
- [[{"field": "founded_year", "conflict": "Legal incorporation and most primary sources say 2017; YC lists Founded: 2018 and George Foot bio says founded with Rosell in 2018", "source_urls": ["https://find-and-update.company-information.service.gov.uk/company/10687784", "https://www.ycombinator.com/companies/sixfold-bioscience", "https://www.sixfold.bio/team"]}, {"field": "founders", "conflict": "YC profile lists only George Foot and Anna Perdrix Rosell; Crick (2018), Tracxn, and patent US10982210B2 also name Zuzanna Brzosko as co-founder/inventor; she resigned as director 2020-08-31", "source_urls": ["https://www.ycombinator.com/companies/sixfold-bioscience", "https://www.crick.ac.uk/news/2018-02-05-crick-phd-student-in-forbes-30-under-30-list", "https://find-and-update.company-information.service.gov.uk/company/10687784/officers", "https://patents.google.com/patent/US10982210B2/en"]}, {"field": "employees", "conflict": "YC reports team_size 27; company site says over 20; DESTINATION.bio says 20 employees — counts and dates may be stale", "source_urls": ["https://www.ycombinator.com/companies/sixfold-bioscience", "https://www.sixfold.bio/team", "https://www.destination.bio/consortium/sixfold-bioscience"]}, {"field": "funding", "conflict": "Only $10.5M total and $2.2M second close are publicly quantified; Tracxn reports 7 rounds with undisclosed per-round amounts; split between dilutive vs non-dilutive not itemized", "source_urls": ["https://www.businesswire.com/news/home/20211202005431/en/Sixfold-Bioscience-Completes-%2410.5M-USD-%C2%A37.8M-GBP-Seed-Financing", "https://tracxn.com/d/companies/sixfold-bioscience/__-qLsHPk8CvZSFLpVir-vQ3yw6SI2DjAKawJ4jJtlXS4"]}, {"field": "yc_investment_amount", "gap": "Y Combinator confirmed as investor but no Sixfold-specific YC check size publicly disclosed", "source_urls": ["https://www.businesswire.com/news/home/20211202005431/en/Sixfold-Bioscience-Completes-%2410.5M-USD-%C2%A37.8M-GBP-Seed-Financing"]}, {"field": "product_focus", "conflict": "2018 Crick article emphasized customizable RNA nanoparticles for cancer drug delivery; current positioning is broader extrahepatic RNA delivery platform (Mergo) for multiple indications", "source_urls": ["https://www.crick.ac.uk/news/2018-02-05-crick-phd-student-in-forbes-30-under-30-list", "https://www.sixfold.bio/platform", "https://www.businesswire.com/news/home/20211202005431/en/Sixfold-Bioscience-Completes-%2410.5M-USD-%C2%A37.8M-GBP-Seed-Financing"]}, {"field": "website_freshness", "gap": "Site footer shows copyright 2023; YC team_size and some third-party profiles may not reflect 2025–2026 headcount", "source_urls": ["https://www.sixfold.bio", "https://www.ycombinator.com/companies/sixfold-bioscience"]}, {"field": "ownership_structure", "gap": "May 2025 PSC filings removed Sixfold Bioscience Inc. as 75%+ shareholder and filed statement of no known registrable PSC; underlying cap table not public", "source_urls": ["https://find-and-update.company-information.service.gov.uk/company/10687784/persons-with-significant-control", "https://find-and-update.company-information.service.gov.uk/company/10687784/filing-history"]}]]
- source urls
- ["https://find-and-update.company-information.service.gov.uk/company/10687784", "https://find-and-update.company-information.service.gov.uk/company/10687784/filing-history", "https://find-and-update.company-information.service.gov.uk/company/10687784/officers", "https://find-and-update.company-information.service.gov.uk/company/10687784/persons-with-significant-control", "https://patents.google.com/patent/US10982210B2/en", "https://patents.google.com/patent/US12472267B2/en", "https://tracxn.com/d/companies/sixfold-bioscience/__-qLsHPk8CvZSFLpVir-vQ3yw6SI2DjAKawJ4jJtlXS4", "https://www.bionity.com/en/companies/1038023/sixfold-bioscience.html", "https://www.businesswire.com/news/home/20211202005431/en/Sixfold-Bioscience-Completes-%2410.5M-USD-%C2%A37.8M-GBP-Seed-Financing", "https://www.crick.ac.uk/news/2018-02-05-crick-phd-student-in-forbes-30-under-30-list", "https://www.destination.bio/consortium/sixfold-bioscience", "https://www.sixfold.bio", "https://www.sixfold.bio/platform", "https://www.sixfold.bio/post/generative-machine-learning-enabled-rna-delivery-receives-ukri-funding", "https://www.sixfold.bio/post/sixfold-bioscience-completes-10-5m-usd-ps7-8m-gbp-seed-financing", "https://www.sixfold.bio/team", "https://www.ycombinator.com/companies/sixfold-bioscience", "https://yc-oss.github.io/api/batches/winter-2018/sixfold-bioscience.json"]